MiR‐378a‐3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation

Abstract Background Hepatocellular carcinoma (HCC) is a malignant disease with high morbidity and mortality, and the molecular mechanism for the genesis and progression is complex and heterogeneous. Biomarker discovery is crucial for the personalized and precision treatment of HCC. The accumulation...

Full description

Bibliographic Details
Main Authors: Fuliang Qian, Jinghan Wang, Ying Wang, Qian Gao, Wenying Yan, Yuxin Lin, Li Shen, Yufeng Xie, Xiaoqing Jiang, Bairong Shen
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/ctm2.307